Doctor profile · Federal record
Dr. MARISSA BARBARO
Neurology Physician (CMS: NEUROLOGY) · MINEOLA, NY
- NPI 1659766046
- Accepts Medicare
- MIPS 84.5 / 100 · 2023
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
120 MINEOLA BLVD
MINEOLA, NY 115014064
(516) 663-9500
fax (516) 663-4613 - Mailing address
-
120 MINEOLA BLVD STE 500
MINEOLA, NY 115014074
Credentials & registration
- NPI registered
- April 2015 — 11 yrs on file
- Profile last updated
- October 7, 2021
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- New York #296900
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659766046. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
396
Distinct HCPCS
3
Medicare allowed
$43,660
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 283 | 109 | $124 | |
36415 |
Insertion of needle into vein for collection of blood sample | 69 | 23 | $8 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 44 | 28 | $179 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 470. This provider delivers 0.8× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
350
Patients
53
Total drug cost
$656,975
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dexamethasone | Generic | 101 | 24 | $1,440 |
| Levetiracetam | Generic | 58 | 15 | $1,653 |
| Pantoprazole Sodium | Generic | 35 | 14 | $238 |
| Gabapentin | Generic | 27 | 0 | $410 |
| Eliquis (Apixaban) | Brand | 21 | 0 | $12,623 |
| Lacosamide | Generic | 19 | 0 | $1,201 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 17 | 0 | $170 |
| Trazodone Hcl | Generic | 14 | 0 | $109 |
| Escitalopram Oxalate | Generic | 13 | 0 | $142 |
| Imbruvica (Ibrutinib) | Brand | 12 | 0 | $629,289 |